cbdMD (YCBD) Non Operating Investment Income (2017 - 2023)
cbdMD (YCBD) posted Non Operating Investment Income of -$700000.0 for Q3 2023, down 35000100.0% sequentially from $2.0 in Q3 2022, and down 35000100.0% YoY from N/an in Q3 2022.
cbdMD (YCBD) Non Operating Investment Income (2017 - 2023) Analysis & Trends
cbdMD has reported Non Operating Investment Income for 4 years, with the latest figure at -$700000.0 in Q3 2023.
- Quarterly Non Operating Investment Income fell 35000100.0% year-over-year to -$700000.0 in Q3 2023, while the trailing twelve-month figure through Sep 2023 was -$700000.0 (down 1999.01% YoY) and the FY2023 annual result came in at -$700000.0, down 1998.95% from the prior year.
- Non Operating Investment Income retreated to -$700000.0 in Q3 2023 per YCBD's latest filing, from $2.0 in the prior quarter.
- Over five years, Non Operating Investment Income peaked at $19938.0 in Q3 2021 and troughed at -$700000.0 in Q3 2023.
- A 3-year average of -$146406.8 and a median of -$18623.0 in 2021 frame the typical range for Non Operating Investment Income.
- The sharpest annual moves came in 2022 and 2023: Non Operating Investment Income sank 99.99% in 2022, then tumbled 35000100.0% in 2023.
- Over 3 years, Non Operating Investment Income stood at -$33351.0 in 2021, then soared by 100.01% to $2.0 in 2022, then sank by 35000100.0% to -$700000.0 in 2023.
- According to Business Quant data, Non Operating Investment Income over the past three periods registered -$700000.0, $2.0, and -$33351.0 for Q3 2023, Q3 2022, and Q4 2021 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | - |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | cbdMD | 5.41 Mn | 3.29 Mn | 3.04 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | -700,000.00 |
| Sep 30, 2023 | -700,000.00 |
| Sep 30, 2022 | 2.00 |
| Sep 30, 2022 | 2.00 |
| Dec 31, 2021 | -33,351.00 |
| Dec 31, 2021 | -33,351.00 |
| Sep 30, 2021 | 19,938.00 |
| Sep 30, 2021 | 19,938.00 |
| Jun 30, 2021 | -18,623.00 |
| Jun 30, 2021 | -18,623.00 |
| Dec 31, 2017 | 33,500.00 |
| Dec 31, 2017 | 33,500.00 |